Parkinson's disease in the Western Pacific Region
Copyright © 2019 Elsevier Ltd. All rights reserved..
1·8 billion people of diverse ethnicities and cultures live in the Western Pacific Region. The increasing longevity of populations in this region is a major contributor to the exponential increase in Parkinson's disease prevalence worldwide. Differences exist between Parkinson's disease in the Western Pacific Region and in Europe and North America that might provide important insights into our understanding of the disease and approaches to management. For example, some genetic factors (such as LRRK2 mutations or variants) differ, environmental exposures might play differential roles in modulating the risk of Parkinson's disease, and fewer dyskinesias are reported, with some differences in the profile of non-motor symptoms and comorbidities. Gaps in awareness of the disease and inequitable access to treatments pose challenges. Further improvements in infrastructure, clinical governance, and services, and concerted collaborative efforts in training and research, including greater representation of the Western Pacific Region in clinical trials, will improve care of patients with Parkinson's disease in this region and beyond.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
---|---|
Enthalten in: |
The Lancet. Neurology - 18(2019), 9 vom: 16. Sept., Seite 865-879 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lim, Shen-Yang [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 09.06.2020 Date Revised 09.06.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/S1474-4422(19)30195-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM297921851 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM297921851 | ||
003 | DE-627 | ||
005 | 20231225093038.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/S1474-4422(19)30195-4 |2 doi | |
028 | 5 | 2 | |a pubmed24n0993.xml |
035 | |a (DE-627)NLM297921851 | ||
035 | |a (NLM)31175000 | ||
035 | |a (PII)S1474-4422(19)30195-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lim, Shen-Yang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Parkinson's disease in the Western Pacific Region |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.06.2020 | ||
500 | |a Date Revised 09.06.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2019 Elsevier Ltd. All rights reserved. | ||
520 | |a 1·8 billion people of diverse ethnicities and cultures live in the Western Pacific Region. The increasing longevity of populations in this region is a major contributor to the exponential increase in Parkinson's disease prevalence worldwide. Differences exist between Parkinson's disease in the Western Pacific Region and in Europe and North America that might provide important insights into our understanding of the disease and approaches to management. For example, some genetic factors (such as LRRK2 mutations or variants) differ, environmental exposures might play differential roles in modulating the risk of Parkinson's disease, and fewer dyskinesias are reported, with some differences in the profile of non-motor symptoms and comorbidities. Gaps in awareness of the disease and inequitable access to treatments pose challenges. Further improvements in infrastructure, clinical governance, and services, and concerted collaborative efforts in training and research, including greater representation of the Western Pacific Region in clinical trials, will improve care of patients with Parkinson's disease in this region and beyond | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
700 | 1 | |a Tan, Ai Huey |e verfasserin |4 aut | |
700 | 1 | |a Ahmad-Annuar, Azlina |e verfasserin |4 aut | |
700 | 1 | |a Klein, Christine |e verfasserin |4 aut | |
700 | 1 | |a Tan, Louis C S |e verfasserin |4 aut | |
700 | 1 | |a Rosales, Raymond L |e verfasserin |4 aut | |
700 | 1 | |a Bhidayasiri, Roongroj |e verfasserin |4 aut | |
700 | 1 | |a Wu, Yih-Ru |e verfasserin |4 aut | |
700 | 1 | |a Shang, Hui-Fang |e verfasserin |4 aut | |
700 | 1 | |a Evans, Andrew H |e verfasserin |4 aut | |
700 | 1 | |a Pal, Pramod K |e verfasserin |4 aut | |
700 | 1 | |a Hattori, Nobutaka |e verfasserin |4 aut | |
700 | 1 | |a Tan, Chong Tin |e verfasserin |4 aut | |
700 | 1 | |a Jeon, Beomseok |e verfasserin |4 aut | |
700 | 1 | |a Tan, Eng-King |e verfasserin |4 aut | |
700 | 1 | |a Lang, Anthony E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Lancet. Neurology |d 2002 |g 18(2019), 9 vom: 16. Sept., Seite 865-879 |w (DE-627)NLM126098468 |x 1474-4465 |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2019 |g number:9 |g day:16 |g month:09 |g pages:865-879 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1474-4422(19)30195-4 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 18 |j 2019 |e 9 |b 16 |c 09 |h 865-879 |